Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients 2021-05-18 08:15
AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community 2021-05-18 04:44
ISMRM Awards Gold Medals At Annual Meeting And Announces New President 2021-05-17 23:00
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines 2021-05-17 20:54
Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037) 2021-05-17 20:35
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors 2021-05-17 20:00
Everest Medicines Announces China NMPA Has Accepted Biologics License Application for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer 2021-05-17 16:51
Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London 2021-05-17 16:00
Nippon Express (China) Becomes First Japanese Company to Acquire GDP Certification in China 2021-05-17 15:00
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting 2021-05-17 09:00
ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension 2021-05-17 08:24
Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial 2021-05-17 08:00
myMedidata Wins 'Best Patient Portal' Award in 2021 MedTech Breakthrough Awards Program 2021-05-14 11:00
Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China 2021-05-14 08:40
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services 2021-05-14 08:30
Transcenta Announces Updated Clinical Data from Phase I Study of pH-Dependent PD-L1 Antibody MSB2311 to Be Presented at the 2021 ASCO Annual Meeting 2021-05-14 08:00
Antengene Announces the Completion of Its Manufacturing Center in Shaoxing to Accelerate the Commercialization of Novel Anti-Cancer Therapies 2021-05-14 08:00
Improving Cancer Survival Prediction: A New Approach with EpiVax Therapeutics' Ancer Platform 2021-05-14 00:28
Noise Suppression Technology - Key to Protecting First Responders, Made Possible by Series A Financing Close 2021-05-13 22:37
LimaCorporate Announces 1st Surgery Using Physica System Trabecular Titanium™ Tibial Plate 2021-05-13 20:00
1 286 287 288 289 290 532